0.00Open0.10Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover674.68%IV7.50%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type0.1182Delta0.1121Gamma326.50Leverage Ratio-7.4135Theta0.0000Rho38.58Eff Leverage0.0005Vega
Federated Hermes Stock Discussion
• $Cadence Design Systems(CDNS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $175 (from $160)
• $Federated Hermes(FHI.US)$ : KBW Upgrades to Outperform from Market Perform - PT $540
• $Goldman Sachs(GS.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $380 (from $360)
• $McDonald's(MCD.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $278 (from $245)
• $Oracle(ORCL.US)$ : Exane Upg...
• $Actinium(ATNM.US)$ +30.81% (Actinum Pharma and Immedica to commercialize lomab-B (1311 apamistamab) in Europe the Middle East and North Africa)
• $Aeglea BioTherapeutics(AGLE.US)$ +18.11% (presents additional data from PEACE phase 3 study of Pegzilarginase; submits BLA to FDA for Pegzilarginase)
• $Grid Dynamics(GDYN.US)$ +5% (expands in Europe ceases operations in Russia)
• $Artisan Partners Asset Management(APAM.US)$ +4....
No comment yet